Who is George Minto, the author of Bio-Heal (OTC: BHLL) Refutes The Our Street Report of Yesterday
George K. Minto
Secretary/Treasurer
Bio-Heal Laboratories, Inc.
George Minto. Mr. Minto has been the president and director of Nutra Pharma,
Inc. since May, 2001, and a director of Nutra Pharma, Inc. since November,
2001. He has also served as the president of Diagnostic Resources since 1999.
He has acted as the Managing Director of Satori Group Trust for the past 30
years. Mr. Minto holds a degree in physiotherapy from the SAME Institute in
Belfast, Ireland, and received pre-medical education at the Queens University
in Belfast. secinfo.com
Nutra Pharma Corp ·
On December 3, 2001, we issued 4,500,000 shares of restricted common stock to
George Guy??? Minto, in exchange for the assets of Nutra Pharma, Inc., which
consisted of a license agreement with TerraBioPharma, S.A., for the worldwide
distribution rights to TerraBioPharma's botanical medicinal compound. On
October 23, 2002, Mr. Minto returned 1,787,500 shares of Nutra Pharma common
stock to the Company for cancellation based on negotiations between the Company
and Mr. Minto.
On December 23, 2002, Nutra Pharma Corp. and Nutra Pharma Inc. mutually agreed
to rescind their agreement dated November 23, 2001. The prior agreement
entitled Nutra Pharma Corp. to acquire all assets of Nutra Pharma Inc. for
4,500,000 shares of Nutra Pharma Corp. All shares were disbursed to George
Minto as the sole shareholder of Nutra Pharma Inc. All shares available will be
returned to Nutra Pharma Corp, all other shares not returned to Nutra Pharma
Corp. will be deemed irretrievable and cancelled upon the agreement.
The final terms and conditions of the agreement are as follows: George Minto
and Nutra Pharma Inc. will return 2,092,500 shares of Nutra Pharma Corp. in
return for 250,000 free-trading shares of Nutra Pharma Corp. George Minto will
deliver an additional 1,000,000 shares of Nutra Pharma Corp. and receive
200,000 shares of Nutra Pharma Corp. The remaining 1,407,500 shares will be
deemed irretrievable and cancelled.
As a result of the cancellation of the above agreement, the Company will remove
the asset and corresponding liability from its balance sheet for the year ended
December 31, 2002. This will result in a decrease of approximately $1,750,000
in assets and a decrease of approximately $1,750,000 in liabilities on Nutra
Pharma Corp.'s balance sheet dated December 31, 2002. |
